Vimarsana
Biggest News Aggregation in the World

Page 3 - Michael Bachner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Bachner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Bachner Today - Breaking & Trending Today

The coin prince: inside Bitcoin's first big money-laundering scandal - Vimarsana News

The coin prince: inside Bitcoin's first big money-laundering scandal

By Adrianne Jeffries and Russell Brandom A week ago, 24-year-old Charlie Shrem landed at JFK, home from giving a talk about the virtual currency Bitcoin at an e-commerce convention in Amsterdam....

Harvey Weinstein's NY rape conviction reversal not surprising to lawyers — but Los Angeles DA claims its sentence is secure - Vimarsana News

Harvey Weinstein's NY rape conviction reversal not surprising to lawyers — but Los Angeles DA claims its sentence is secure

The reversal of Harvey Weinstein’s New York rape conviction, while “disheartening,” didn’t come as a surprise to legal experts.

Source: nypost.com
What's next for Harvey Weinstein? - Vimarsana News

What's next for Harvey Weinstein?

Disgraced former Hollywood mogul Harvey Weinstein will go through hearings on bail and learn if he has to be extradited to Los Angeles after his sex crime conviction was overturned in New York on Thursday.

Source: nypost.com
Trump trial illustrates jury challenges in the social media age - Vimarsana News

Trump trial illustrates jury challenges in the social media age

Donald Trump's criminal trial in New York has barely begun but one of the highest-profile court cases in U.S. history has already highlighted the challenges of insulating a jury from social...

Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 - Vimarsana News

Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024

DUBLIN--(BUSINESS WIRE)--$PRTA #prothena--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it will report its fourth quarter and full year 2023 financial results on...